Invisio AB (publ) - IVSO.ST

IVSO.ST Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
IVSO.ST	-0.3	13.7	21.1	29.1	34.9	61.4	180.4	133.2	2457.7	1352.6
S&P 500	-0.3	1.4	1.1	5.0	11.8	24.7	40.3	88.1	196.6	34448.4

Compare IVSO.ST with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	IVSO.ST
name	Invisio AB (publ)
price	332.5
changes percentage	-0.2999
change	-1
day low	323.5
day high	336
year high	343
year low	199.6
market cap	15158741500
price avg 50	278.48
price avg 200	253.075
exchange	STO
volume	79113
avg volume	56731
open	334
previous close	333.5
eps	4.36
pe	76.26
earnings announcement	2025-02-13T13:00:00.000+0000
shares outstanding	45590200
timestamp	2025-01-24 16:29:45

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 55.3%

Overall Quarterly Financial Health: 52.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	1238500000	775500000	59.70
gross profit	747300000	449800000	66.14
gross profit ratio	0.6	0.58	4.03
research and development expenses	141600000	109200000	29.67
operating expenses	504400000	384500000	31.18
interest income	8800000	4100000	114.63
interest expense	9800000	6800000	44.12
ebitda	285600000	96100000	197.19
ebitdaratio	0.23	0.15	52.72
operating income	242900000	65200000	272.55
operating income ratio	0.2	0.08	133.27
net income	178400000	44500000	300.90
net income ratio	0.14	0.06	151.03
eps	3.91	0.99	294.95

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 1,238 million in 2023 from 776 million in 2022 representing a change of 59.7%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 504 million in 2023 from 384 million in 2022 representing a change of 31.18%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 286 million in 2023 from 96 million in 2022 representing a change of 197.19%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 243 million in 2023 from 65 million in 2022 representing a change of 272.55%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 178 million in 2023 from 44 million in 2022 representing a change of 300.9%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 747 million in 2023 from 450 million in 2022 representing a change of 66.14%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 142 million in 2023 from 109 million in 2022 representing a change of 29.67%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Earnings per Share (EPS): EPS increased to 3.91 in 2023 from 3.91 in 2022 representing a change of 294.95%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	351700000	552700000	-36.37
gross profit	192800000	247600000	-22.13
gross profit ratio	0.55	0.45	22.37
research and development expenses	5600000	5500000	1.82
operating expenses	135500000	147900000	-8.38
interest income	0	1100000	-100.00
interest expense	3600000	0	NaN
ebitda	67300000	109500000	-38.54
ebitdaratio	0.19	0.2	-3.41
operating income	57300000	99700000	-42.53
operating income ratio	0.16	0.18	-9.68
net income	38900000	73900000	-47.36
net income ratio	0.11	0.13	-17.28
eps	0.85	1.62	-47.53

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 352 million in 2024Q3 from 553 million in 2024Q2 representing a change of -36.37%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 193 million in 2024Q3 from 248 million in 2024Q2 representing a change of -22.13%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Income: Operating income decreased to 57 million in 2024Q3 from 100 million in 2024Q2 representing a change of -42.53%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 39 million in 2024Q3 from 74 million in 2024Q2 representing a change of -47.36%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.85 in 2024Q3 from 0.85 in 2024Q2 representing a change of -47.53%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 6 million in 2024Q3 from 6 million in 2024Q2 representing a change of 1.82%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 136 million in 2024Q3 from 148 million in 2024Q2 representing a change of -8.38%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 67 million in 2024Q3 from 110 million in 2024Q2 representing a change of -38.54%. The increase in EBITDA indicates improved operational efficiency and profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1053000000	799900000	31.64
total liabilities	332600000	290000000	14.69
total equity	720400000	509900000	41.28
cash and cash equivalents	224900000	127100000	76.95
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	742500000	511000000	45.30
total non current assets	310500000	288900000	7.48
total current liabilities	268100000	194300000	37.98
total non current liabilities	64500000	95700000	-32.60
common stock	45600000	45000000	1.33
retained earnings	216600000	60100000	260.40
total debt	37800000	89800000	-57.91

Overall Score of Annual Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,053 million in 2023 from 800 million in 2022 representing a change of 31.64%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 720 million in 2023 from 510 million in 2022 representing a change of 41.28%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 225 million in 2023 from 127 million in 2022 representing a change of 76.95%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 742 million in 2023 from 511 million in 2022 representing a change of 45.3%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 46 in 2023 from 45 in 2022 representing a change of 1.33%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 217 million in 2023 from 60 million in 2022 representing a change of 260.4%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 38 million in 2023 from 90 million in 2022 representing a change of -57.91%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 333 million in 2023 from 290 million in 2022 representing a change of 14.69%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 268 million in 2023 from 194 million in 2022 representing a change of 37.98%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	1223300000	1137000000	7.59
total liabilities	377500000	331700000	13.81
total equity	845800000	805300000	5.03
cash and cash equivalents	242700000	112300000	116.12
short term investments	0	0	NaN
long term investments	0	194300000	-100.00
total current assets	881200000	800400000	10.09
total non current assets	342100000	336600000	1.63
total current liabilities	317100000	267500000	18.54
total non current liabilities	60400000	64199999	-5.92
common stock	0	805300000	-100.00
retained earnings	0	0	NaN
total debt	31000000	34100000	-9.09

Overall Score of Quarterly Balance Sheet

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,223 million in 2024Q3 from 1,137 million in 2024Q2 representing a change of 7.59%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 846 million in 2024Q3 from 805 million in 2024Q2 representing a change of 5.03%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 243 million in 2024Q3 from 112 million in 2024Q2 representing a change of 116.12%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 881 million in 2024Q3 from 800 million in 2024Q2 representing a change of 10.09%. This indicates a better liquidity position.

  Total Debt: Total Debt decreased to 31 million in 2024Q3 from 34 million in 2024Q2 representing a change of -9.09%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 378 million in 2024Q3 from 332 million in 2024Q2 representing a change of 13.81%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 317 million in 2024Q3 from 268 million in 2024Q2 representing a change of 18.54%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 0 in 2024Q3 from 805 in 2024Q2 representing a change of -100.0%. This indicates a decrease in ownership interest.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	97800000	-7700000	1370.13
operating cash flow	204700000	41700000	390.89
free cash flow	151300000	8200000	1745.12
capital expenditure	-53400000	-33500000	-59.40
depreciation and amortization	33900000	47800000	-29.08
deferred income tax	0	0	NaN
stock based compensation	9600000	4500000	113.33
accounts payables	68500000	26800000	155.60
inventory	-98500000	-13900000	-608.63
acquisitions net	0	0	NaN
investments in property plant and equipment	-21000000	-33500000	37.31
net cash used for investing activites	-55000000	-33500000	-64.18
debt repayment	-65000000	-20000000	-225.00
common stock issued	58600000	36000000	62.78
common stock repurchased	0	0	NaN
dividends paid	-31500000	-31200000	-0.96
net cash used provided by financing activities	-48500000	-25100000	-93.23
cash at end of period	224900000	127100000	76.95
accounts receivables	-48800000	-81900000	40.42
cash at beginning of period	127100000	134800000	-5.71

Overall Score of Annual Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 98 million in 2023 from -8 million in 2022 representing a change of 1370.13%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 205 million in 2023 from 42 million in 2022 representing a change of 390.89%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 151 million in 2023 from 8 million in 2022 representing a change of 1745.12%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -53 million in 2023 from -34 million in 2022 representing a change of -59.4%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Stock-Based Compensation: Stock-Based Compensation increased to 10 million in 2023 from 4 million in 2022 representing a change of 113.33%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 68 million in 2023 from 27 million in 2022 representing a change of 155.6%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to -49 in 2023 from -82 million in 2022 representing a change of 40.42%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -32 million in 2023 from -31 million in 2022 representing a change of -0.96%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	152600000	-35300000	532.29
free cash flow	135500000	-56400000	340.25
capital expenditure	-17100000	-21100000	18.96
depreciation and amortization	0	9800000	-100.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	75700000	-127500000	159.37
accounts payables	38600000	25700000	50.19
inventory	-31300000	-24400000	-28.28
acquisitions net	0	0	NaN
investments in property plant and equipment	-3000000	-21100000	85.78
net cash used for investing activites	-17400000	-21100000	17.54
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	-59300000	100.00
net cash used provided by financing activities	-3200000	-62900000	94.91
net change in cash	130400000	-120700000	208.04
cash at end of period	242700000	112300000	116.12
cash at beginning of period	112300000	233000000	-51.80

Overall Score of Quarterly Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 130 million in 2024Q3 from -121 million in 2024Q2 representing a change of 208.04%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 153 million in 2024Q3 from -35 million in 2024Q2 representing a change of 532.29%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 136 million in 2024Q3 from -56 million in 2024Q2 representing a change of 340.25%. This indicates an increase in cash generated after accounting for capital expenditures.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q3 from -59 million in 2024Q2 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -17 million in 2024Q3 from -21 million in 2024Q2 representing a change of 18.96%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 39 million in 2024Q3 from 26 million in 2024Q2 representing a change of 50.19%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 76 in 2024Q3 from -128 million in 2024Q2 representing a change of 159.37%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	27.17	17.3	57.07
net income per share	3.91	0.99	294.29
operating cash flow per share	4.49	0.93	382.79
free cash flow per share	3.32	0.18	1714.69
cash per share	4.93	2.83	74.03
book value per share	15.8	11.37	38.95
tangible book value per share	10.61	6.04	75.68
shareholders equity per share	15.8	11.37	38.95
interest debt per share	1.04	2.15	-51.54
market cap	8917404000	7380334800	20.83
enterprise value	8730304000	7343034800	18.89
pe ratio	49.99	165.85	-69.86
price to sales ratio	7.2	9.52	-24.34
pocfratio	43.56	176.99	-75.39
pfcf ratio	58.94	900.04	-93.45
pb ratio	12.38	14.47	-14.48
ptb ratio	12.38	14.47	-14.48
ev to sales	7.05	9.47	-25.55
enterprise value over ebitda	30.57	76.41	-59.99
ev to operating cash flow	42.65	176.09	-75.78
ev to free cash flow	57.7	895.49	-93.56
earnings yield	0.02	0.01	231.80
free cash flow yield	0.02	0.0	1427.08
debt to equity	0.05	0.18	-70.21
debt to assets	0.04	0.11	-68.02
net debt to ebitda	-0.66	-0.39	-68.78
current ratio	2.77	2.63	5.31
interest coverage	24.79	9.59	158.50
income quality	1.15	0.67	71.98
dividend yield	0.0	0.0	-16.44
payout ratio	0.18	0.7	-74.82
sales general and administrative to revenue	0.09	0.11	-17.74
research and ddevelopement to revenue	0.11	0.14	-18.81
intangibles to total assets	0.22	0.3	-24.83
capex to operating cash flow	0.26	0.8	-67.53
capex to revenue	0.04	0.04	-0.19
capex to depreciation	1.58	0.7	124.76
stock based compensation to revenue	0.01	0.01	33.58
graham number	37.3	15.94	134.07
roic	0.23	0.07	207.57
return on tangible assets	0.22	0.08	175.40
graham net net	3.86	1.23	213.77
working capital	474400000	316700000	49.79
tangible asset value	483900000	270900000	78.63
net current asset value	409900000	221000000	85.48
invested capital	778100000	599400000	29.81
average receivables	207000000	156050000	32.65
average payables	87700000	55250000	58.73
average inventory	191300000	130950000	46.09
days sales outstanding	64.69	91.54	-29.34
days payables outstanding	81.14	74.19	9.38
days of inventory on hand	177.0	161.82	9.38
receivables turnover	5.64	3.99	41.51
payables turnover	4.5	4.92	-8.57
inventory turnover	2.06	2.26	-8.57
roe	0.25	0.09	183.76
capex per share	1.17	0.75	56.77

• Positive

  ROE: Return on Equity (ROE) increased to 0.25 on 2023-12-31 from 0.09 on 2022-12-31, representing a change of 183.76%. Suggesting the company has been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 2.77 on 2023-12-31 from 2.63 on 2022-12-31, representing a change of 5.31%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.05 on 2023-12-31 from 0.18 on 2022-12-31, representing a change of -70.21%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 49.99 on 2023-12-31 from 165.85 on 2022-12-31, representing a change of -69.86%. Indicating a decrease in the relative valuation of the company's stock.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
IVSO.ST
calendar year	2024	2024	NaN
revenue per share	7.71	12.12	-36.37
net income per share	0.85	1.62	-47.36
operating cash flow per share	3.35	-0.77	532.29
free cash flow per share	2.97	-1.24	340.25
cash per share	5.32	2.46	116.12
book value per share	18.55	17.66	5.03
tangible book value per share	12.83	12.06	6.35
shareholders equity per share	18.55	17.66	5.03
interest debt per share	0.76	0.75	1.47
market cap	10531290000	10599675000	-0.65
enterprise value	10319590000	10521475000	-1.92
pe ratio	67.68	35.86	88.75
price to sales ratio	29.94	19.18	56.14
pocfratio	69.01	-300.27	122.98
pfcf ratio	77.72	-187.94	141.36
pb ratio	12.45	13.16	-5.40
ptb ratio	12.45	13.16	-5.40
ev to sales	29.34	19.04	54.14
enterprise value over ebitda	153.34	96.09	59.58
ev to operating cash flow	67.63	-298.06	122.69
ev to free cash flow	76.16	-186.55	140.82
earnings yield	0.0	0.01	-47.02
free cash flow yield	0.01	-0.01	341.81
debt to equity	0.04	0.04	-13.44
debt to assets	0.03	0.03	-15.50
net debt to ebitda	-3.15	-0.71	-340.47
current ratio	2.78	2.99	-7.13
interest coverage	15.92	0	NaN
income quality	2.84	-0.48	694.91
dividend yield	0	0.01	-100.00
payout ratio	0	0.8	-100.00
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.02	0.01	60.01
intangibles to total assets	0.21	0.22	-5.02
capex to operating cash flow	0.11	-0.6	118.75
capex to revenue	0.05	0.04	27.36
capex to depreciation	0	2.15	-100.00
stock based compensation to revenue	0	0	NaN
graham number	18.87	25.38	-25.65
roic	0.05	0.08	-45.47
return on tangible assets	0.04	0.08	-51.78
graham net net	5.88	3.69	59.63
working capital	564100000	532900000	5.85
tangible asset value	584800000	549900000	6.35
net current asset value	503700000	468700000	7.47
invested capital	887500000	854300000	3.89
average receivables	334500000	166950000	100.36
average payables	110750000	102050000	8.53
average inventory	288700000	263000000	9.77
days sales outstanding	85.75	54.37	57.72
days payables outstanding	65.48	31.24	109.59
days of inventory on hand	171.84	80.83	112.61
receivables turnover	1.05	1.66	-36.59
payables turnover	1.37	2.88	-52.29
inventory turnover	0.52	1.11	-52.97
roe	0.05	0.09	-49.88
capex per share	0.38	0.46	-18.96

• Negative

  ROE: Return on Equity (ROE) decreased to 0.05 on 2024-09-30 Q3 from 0.09 on 2024-06-30 Q2, representing a change of -49.88%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 67.68 on 2024-09-30 Q3 from 35.86 on 2024-06-30 Q2, representing a change of 88.75%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.04 on 2024-09-30 Q3 from 0.04 on 2024-06-30 Q2, representing a change of -13.44%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 2.78 on 2024-09-30 Q3 from 2.99 on 2024-06-30 Q2, representing a change of -7.13%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 172.44 which is lower than current price 332.5, indicates the company may be overvalued.